Scaling Radiopharmaceutical Supply Chains for Late-Stage and Commercial Therapeutics
- Scaling Challenges (Phase II to III): Batch scheduling constraints and mismatches between isotope supply and manufacturing capacity
- Manufacturing Models: Trade-offs between centralized hubs and distributed radiopharmacy networks
- Supply/Demand Coordination: Aligning isotope availability with patient and site demand for manufacturing capacity
- Operational Execution: QC release timing and treatment center scheduling across multi-site networks
- Lessons Learned: Insights from recent radiotherapeutic launches